“Atmospheric” alterations are key aspects of altered subjectivity in mental disorder. Karl Jaspers famously described the “delusional mood”: a sense of uncanny salience and ominousness that often precedes the onset of schizophrenic psychosis or of delusions. Such experiences, he writes, involve “a transformation in our total awareness of reality” that often verges on ineffability. In psychiatry, these experiential alterations are often referred to in terms of “derealization.” Though derealization most obviously refers to a decline in the sense of objective presence or felt actuality, it can also refer to other unusual experiences in which things seem unlike normal or standard reality, including altered familiarity, vitality, meaning, or relevance. This paper first describes two complementary ways of approaching these phenomena: the notion of an “ontological” dimension (Sass) and that of “existential feeling” (Ratcliffe). It then offers a wider-ranging synopsis of work in phenomenological psychopathology that has sought to address atmospheric alterations believed to be especially characteristic of schizophrenia spectrum conditions, focusing on the themes of a diminished sense of reality, altered sense of meaning, disrupted feeling of familiarity, and diminished vitality and relevance.

1.
Jaspers K: General Psychopathology. Chicago, University of Chicago Press, 1963.
2.
Fuchs T: Delusional mood and delusional perception - a phenomenological analysis. Psychopathology 2005;38:133-139.
3.
Sass L: Madness and Modernism: Insanity in the Light of Modern Art, Literature, and Thought. New York, Basic Books, 1992.
4.
Minkowski E: Lived Time. Evanston, Northwestern University Press, 1970.
5.
Frosch J: The psychotic character: clinical psychiatric considerations. Psychiatr Q 1964;38:81-96.
6.
Sass L, Pienkos E, Nelson B, Medford N: Anomalous self-experience in depersonalization and schizophrenia: a comparative investigation. Conscious Cogn 2013;22:430-431.
7.
Heidegger M: Being and Time: A Translation of Sein und Zeit. Albany, State University of New York Press, 1996.
8.
Fink E: Sixth Cartesian Meditation: The Idea of a Transcendental Theory of Method. Bloomington, Indiana University Press, 1995.
9.
Sass L: Jaspers, phenomenology, and the “ontological difference”; in Stanghellini G, Fuchs T (eds): One Century of Karl Jaspers' General Psychopathology. Oxford, Oxford University Press, 2013.
10.
Ratcliffe M: The feeling of being. J Conscious Stud 2005;12:43-60.
11.
Ratcliffe M: Feelings of Being: Phenomenology, Psychiatry, and the Sense of Reality. Oxford, Oxford University Press, 2008.
12.
Sass L: Heidegger, schizophrenia, and the ontological difference. Philos Psychol 1992;5:109-132.
13.
Sass L: Affectivity in schizophrenia: a phenomenological perspective. J Conscious Stud 2004;11:127-147.
14.
Sass L: Contradictions of emotion in schizophrenia. Cogn Emotion 2007;21:351-390.
15.
Ratcliffe M: Experiences of Depression: A Study in Phenomenology. Oxford, Oxford University Press, 2015.
16.
Fuchs T: Corporealized and disembodied minds: a phenomenological view of the body in melancholia and schizophrenia. Philos Psychiatry Psychol 2005;12:95-107.
17.
Cutting J, Dunne F: Subjective experience of schizophrenia. Schizophr Bull 1989;15:217-231.
18.
Sass L, Pienkos E: Space, time, and atmosphere: a comparative phenomenology of melancholia, mania, and schizophrenia. Part II. J Conscious Stud 2013;20:131-152.
19.
James W: The Principles of Psychology (1890). Cambridge, Harvard University Press, 1981.
20.
Aggernaes A: The experienced reality of hallucinations and other psychological phenomena: an empirical analysis. Acta Psychiatr Scand 1972;48:220-238.
21.
Sass L: The Paradoxes of Delusion. Ithaca, Cornell University Press, 1994.
22.
Sass L: Delusion and double bookkeeping; in Fuchs T, Breyer T, Mundt C (eds): Karl Jaspers' Philosophy and Psychopathology. New York, Springer, 2014, pp 125-147.
23.
van den Berg JH: A Different Existence: Principles of Phenomenological Psychopathology. Pittsburgh, Duquesne University Press, 1972.
24.
Laing RD: The Divided Self: An Existential Study in Sanity and Madness. Harmondsworth, Penguin, 1965.
25.
Sechehaye M: Autobiography of a Schizophrenic Girl. New York, Signet, 1970.
26.
Conrad K: La esquizofrenia incipiente (1958). Madrid, Fundación Archivos de Neurobiologia, 1997.
27.
Sass L, Pienkos E: Delusions: the phenomenological approach; in Fulford W, Davies M, Graham G, Sadler J, Stanghellini G (eds): Oxford Handbook of Philosophy of Psychiatry. Oxford, Oxford University Press, 2013.
28.
Matussek P: Studies in delusional perception; in Cutting J, Shepherd M (eds): The Clinical Roots of the Schizophrenia Concept. Cambridge, Cambridge University Press, 1987, pp 89-103.
29.
Binswanger L: Extravagance, perverseness, manneristic behavior and schizophrenia; in Cutting J, Shepherd M (eds): The Clinical Roots of the Schizophrenia Concept. Cambridge, Cambridge University Press, 1987, pp 83-88.
30.
Binswanger L: Schizophrenie. Pfullingen, Neske, 1957.
31.
Blankenburg W: La perte de l'évidence naturelle: une contribution à la psychopathologie des schizophrénies pauci-symptomatiques (1971). Paris, Presses Universitaires de France, 1991.
32.
Störring G: Perplexity; in Cutting J, Shepherd M (eds): The Clinical Roots of the Schizophrenia Concept. Cambridge, Cambridge University Press, 1987, pp 79-82.
33.
Minkowski E: La schizophrénie. Paris, Payot, 1927.
34.
Sass L: Self and world in schizophrenia: three classic approaches. Philos Psychiatry Psychol 2001;8:251-270.
35.
Sass L: Schizophrenia: a disturbance of the thematic field; in Embree L (ed): Gurwitsch's Relevancy for the Cognitive Sciences. Dordrecht, Springer, 2004, pp 59-78.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.